Yep, completely acknowledge that in my haste they actually aren't that reflective of the "profit" the company will make.
2 additional points,
- I forgot to deduct the $160m growth capital from the $575m "profit" that is called out in the slides - so more like $415m "profit" (but as you said, not actually profit)
- although the hedge book (thankfully) gets lower each quarter, I believe the company has made the amount consistent across all remaining payments here on out, so it is more like a fixed cost.
Let's say $115m in "other costs" gives us a "profit" of $300m.
$1,600m market cap / $300m "profit" = PE of 5.3.
Completely, and utterly bonkers.
Again, apologies for misleading anyone.
- Forums
- ASX - By Stock
- Under valued
Yep, completely acknowledge that in my haste they actually...
-
-
- There are more pages in this discussion • 971 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RRL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.07 |
Change
0.080(4.02%) |
Mkt cap ! $1.563B |
Open | High | Low | Value | Volume |
$2.01 | $2.08 | $2.00 | $16.21M | 7.870M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 88839 | $2.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.08 | 69643 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 85092 | 2.060 |
3 | 38314 | 2.050 |
1 | 3607 | 2.040 |
5 | 29459 | 2.030 |
3 | 6007 | 2.020 |
Price($) | Vol. | No. |
---|---|---|
2.080 | 65590 | 10 |
2.090 | 242232 | 19 |
2.100 | 239049 | 20 |
2.110 | 97773 | 6 |
2.120 | 81998 | 15 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online